Chemotherapy in stage IV (metastatic) non-small-cell lung cancer

Cancer Prevention and Control

Volumn 1, Issue 1, 1997, Pages 18-27

  Lopez, P G ^a   Stewart, D J ^a   Newman, T E ^a   Evans, W K ^a   Alam, Y ^a   Campling, B ^a   Chamberlain, D ^a   Darling, G ^a   Dixon, P ^a   Feld, R ^a   Findlay, B ^a   Goss, G ^a   Graham, I ^a   Iscoe, N ^a   Kochna, W ^a   Kolin, A ^a   Kotalik, J ^a   Laupacis, A ^a   Lochrin, C A ^a   Logan, D ^a   Malthaner, R ^a   Miller, J ^a   Okawara, G ^a   Paszat, L ^a   Reid, K ^a   Rusthoven, J J ^a   Sellick, S ^a   Shepherd, F ^a   Stewart, D ^a   Vincent, M ^a   Wenckebach, G ^a   Yoshida, S ^a   Yu, E ^a   more..

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; MITOMYCIN; VINBLASTINE; VINDESINE;

BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TOXICITY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; NEPHROTOXICITY; NEUROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; QUALITY OF LIFE;

EID: 17344388466     PISSN: 1206548X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)